Long term treatment study of KRP-108 for adult asthmatic patients.

Trial Profile

Long term treatment study of KRP-108 for adult asthmatic patients.

Completed
Phase of Trial: Phase III

Latest Information Update: 20 May 2016

At a glance

  • Drugs Formoterol/fluticasone propionate (Primary)
  • Indications Asthma
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Sponsors Kyorin Pharmaceutical
  • Most Recent Events

    • 25 Jun 2012 Primary endpoint (unspecified) has been met.
    • 01 Jun 2012 Status changed from recruiting to completed.
    • 24 Mar 2011 Recruitment is on target as reported by SkyePharma PLC.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top